MedTrace Logo

Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing

NCT04584047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-01-31

No results posted yet for this study

Summary

The study aims to investigate whether cell-based non-invasive prenatal testing (cbNIPT) can be used as an alternative to invasive chorionic villus sampling (CVS) in patients who achieve pregnancy following preimplantation genetic testing for monogenic disorders (PGT-M).

Conditions

  • Prenatal Diagnoses
  • Preimplantation Genetic Diagnosis

Interventions

PROCEDURE

Cell-based non-invasive prenatal testing

Blood sampling.

Sponsors & Collaborators

  • Arcedi Biotech

    collaborator INDUSTRY

  • Aarhus University Hospital

    collaborator OTHER

  • Viborg Regional Hospital

    collaborator OTHER

  • Horsens Hospital

    collaborator OTHER

  • Randers Regional Hospital

    collaborator OTHER

  • Kolding Sygehus

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-18
Primary Completion
2019-11-21
Completion
2019-11-21

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584047 on ClinicalTrials.gov